Medication info

Gastrografin

Prescription medicationSolution
Ingredient · strength
Amidotrizoic Acid›59.73g / 1 bottleMeglumine›15.924g / 1 bottleSodium Hydroxide›0.629g / 1 bottle
Manufacturer / importer
Bayer korea
Appearance
A slightly yellowish, nearly colorless solution contained in a brown bottle with a faint star anise scent.
Packaging
1CTN: 100ML × 1
Approval status
Active

MFDS item code 200800685 · Notified 2008.01.17 · Insurance code 641100411

Summary

Main use
Improves gastrointestinal contrast examinations and early detection of perforations and anastomotic leaks
Who uses it
Adults · Children
Adult dosage
1. Monotherapy 1) Oral administration The dose of this product varies depending on the area to be imaged and the patient's age. For imaging of the stomach, 60 mL is sufficient for adults, while up to 100 mL may be required for continuous imaging of the gastrointestinal tract. In elderly patients or patients with cachexia, it is preferable to dilute the product with an equal volume of water before administration. For the early diagnosis of perforation of the esophagus or gastrointestinal tract, or a defect at an anastomosis, administer 100 mL of this product. 2) Rectal administration For administration to adults, dilute this product with 3∼4 times its volume of water. Unlike rectal administration of barium sulfate, this product generally does not require more than 500 mL of diluted solution. 2. Concomitant use of this product and barium sulfate For adults, it is appropriate to add 30 mL of this product to the usual amount of barium sulfate. In cases of pylorospasm or pyloric stenosis, the proportion of this product added to the suspension may be increased further if necessary; this does not affect the imaging results. Imaging of the stomach is performed using the usual method, whether this product is administered alone or concomitantly with barium sulfate. This product takes slightly less time to pass through the intestine than barium sulfate. When this product is used alone, it generally reaches the rectum after 2 hours; when used concomitantly with barium sulfate, it takes 3 hours and may take longer in certain circumstances. The most suitable time for colonic imaging is when the contrast agent has reached the rectum and all patients feel an urgent need to defecate.
Children's dosage
1. Monotherapy 1) Oral administration Children aged 10 years and older: 60 mL is sufficient for imaging of the stomach, while up to 100 mL may be required for continuous imaging of the gastrointestinal tract. Children under 10 years: 15∼30 mL is sufficient and may be administered diluted with 2 times its volume of water. For infants and young children, dilution with 3 times the volume of water is recommended. 2) Rectal administration Children aged 5 years and older: Dilute this product with 4∼5 times its volume of water before use. Children under 5 years: It is preferable to dilute this product with 5 times its volume of water before use. 2. Concomitant use of this product and barium sulfate Children aged 5∼10 years: It is appropriate to add 10 mL of this product to 100 mL of barium sulfate suspension. Children under 5 years: It is appropriate to add 2∼5 mL.

Ingredients

Importer
Bayer korea

Efficacy & effects

Improves gastrointestinal contrast examinations and early detection of perforations and anastomotic leaks

  • Partial obstruction
  • complete obstruction
  • acute bleeding
  • urgent perforation
  • gastric ulcer
  • diverticulitis
  • acute conditions
  • risk of defect after gastric and intestinal resections
  • colon syndrome
  • foreign bodies
  • tumors
  • gastrointestinal fistulas
View approved original text

This drug can be administered orally or by enema as a contrast agent for gastrointestinal examinations. It is primarily used in cases where barium sulfate is unsuitable or ineffective, particularly when partial or complete obstruction is suspected, acute bleeding occurs, urgent perforation, acute surgical conditions arise, post-operative complications in stomach and intestinal resections, colon syndrome, pre-endoscopic examination of foreign bodies and tumors, and particularly for imaging gastrointestinal fistulas. Moreover, it can enhance diagnostic efficacy in conjunction with barium sulfate but is not recommended for the diagnosis of enteritis. This medication is also used for the early diagnosis of perforations or suture defects in the esophagus or gastrointestinal tract that are difficult to identify radiologically. Overall, this drug is useful for improving the diagnosis of various gastrointestinal-related conditions.

Dosage and Administration

Adult dosage

1. Monotherapy 1) Oral administration The dose of this product varies depending on the area to be imaged and the patient's age. For imaging of the stomach, 60 mL is sufficient for adults, while up to 100 mL may be required for continuous imaging of the gastrointestinal tract. In elderly patients or patients with cachexia, it is preferable to dilute the product with an equal volume of water before administration. For the early diagnosis of perforation of the esophagus or gastrointestinal tract, or a defect at an anastomosis, administer 100 mL of this product. 2) Rectal administration For administration to adults, dilute this product with 3∼4 times its volume of water. Unlike rectal administration of barium sulfate, this product generally does not require more than 500 mL of diluted solution. 2. Concomitant use of this product and barium sulfate For adults, it is appropriate to add 30 mL of this product to the usual amount of barium sulfate. In cases of pylorospasm or pyloric stenosis, the proportion of this product added to the suspension may be increased further if necessary; this does not affect the imaging results. Imaging of the stomach is performed using the usual method, whether this product is administered alone or concomitantly with barium sulfate. This product takes slightly less time to pass through the intestine than barium sulfate. When this product is used alone, it generally reaches the rectum after 2 hours; when used concomitantly with barium sulfate, it takes 3 hours and may take longer in certain circumstances. The most suitable time for colonic imaging is when the contrast agent has reached the rectum and all patients feel an urgent need to defecate.

Children's dosage

1. Monotherapy 1) Oral administration Children aged 10 years and older: 60 mL is sufficient for imaging of the stomach, while up to 100 mL may be required for continuous imaging of the gastrointestinal tract. Children under 10 years: 15∼30 mL is sufficient and may be administered diluted with 2 times its volume of water. For infants and young children, dilution with 3 times the volume of water is recommended. 2) Rectal administration Children aged 5 years and older: Dilute this product with 4∼5 times its volume of water before use. Children under 5 years: It is preferable to dilute this product with 5 times its volume of water before use. 2. Concomitant use of this product and barium sulfate Children aged 5∼10 years: It is appropriate to add 10 mL of this product to 100 mL of barium sulfate suspension. Children under 5 years: It is appropriate to add 2∼5 mL.

Precautions

This medication contains iodine, therefore it should not be used in patients with an allergy to iodine or those who have had hypersensitivity reactions to this drug or similar medications. It should also be avoided in patients with excessively activated thyroid function. Caution is necessary for patients with bronchial asthma or a tendency to easily develop skin allergy reactions. In patients with enteritis or colitis, caution is advised as symptoms may worsen. Children and dehydrated patients are at higher risk of complications due to decreased blood volume, so caution is needed. In patients suspected of having bronchial aspiration or tracheoesophageal leak, serious pulmonary complications may occur due to the hyperosmolar nature of this drug. Patients with intestinal obstruction should use this drug cautiously as prolonged contact with the intestinal mucosa can cause damage. Patients with asymptomatic hyperthyroidism or benign nodular goiter may also experience worsened symptoms due to this drug. Women who are pregnant or may become pregnant should discuss the use of this drug with their physician and should only be administered when the diagnostic necessity is substantial. This drug can rarely cause severe allergic reactions or shock, so careful monitoring of the patient's condition during administration is required and prompt treatment should be provided if any unusual symptoms arise. Gastrointestinal side effects may include nausea, vomiting, abdominal pain, diarrhea; delayed gastrointestinal elimination may lead to serious issues like tissue damage or bleeding. Cardiovascular side effects such as hypotension or tachycardia can occur rarely. The drug may affect thyroid function, leading to hyperthyroidism or hypothyroidism; thus, patients with thyroid disease should be cautious. In the central nervous system, side effects may include seizures, headache, and dizziness. Respiratory side effects may include bronchial dilation or breathing difficulties, pneumonia, and pulmonary edema occurring rarely. In terms of skin reactions, urticaria, rashes, itching, and in severe cases, toxic epidermal necrolysis (Stevens-Johnson syndrome) may occur. This drug must be used according to the instructions of an experienced professional, and thorough medical history and emergency measures should be prepared in anticipation of the possibility of hypersensitivity reactions. Post-administration, vital signs of the patient should continue to be monitored, and if any adverse reactions occur, administration should be stopped immediately and appropriate treatment should be initiated. Delayed adverse reactions may appear several hours to days after administration, requiring adequate explanation to the patient and guidance to consult medical personnel if symptoms arise. Patients with cardiovascular diseases should be particularly cautious as severe hypersensitivity reactions can lead to fatal outcomes. This drug may influence thyroid function, potentially triggering or worsening hyperthyroidism, so patients with thyroid diseases should consider thyroid function tests and preventive measures prior to administration. When administering to pregnant women or children, consultation with a physician is essential due to the presence of saccharin. Due to the hyperosmolar nature of this drug, dehydration or electrolyte imbalance may arise, so adequate hydration and electrolyte status should be assessed before administration, particularly for children, dehydrated patients, and the elderly. This drug is prohibited from intravenous injection; it must be diluted when administered rectally. Once opened, it must be used within 24 hours, and before use, ensure that there are no particulates in the solution. Additionally, this drug can affect certain clinical test results, so care should be taken before and after undergoing thyroid function tests or pancreatic function tests.

Side effects

  • shock
  • anaphylactic reaction
  • syncope
  • loss of consciousness
  • dyspnea
  • respiratory arrest
  • cardiac arrest
  • angioedema
  • facial swelling
  • nausea
Show 28 more
  • vomiting
  • abdominal pain
  • abdominal discomfort
  • oral mucosal blistering
  • diarrhea
  • tissue damage
  • gastrointestinal bleeding
  • bowel necrosis
  • intestinal perforation
  • hypotension
  • tachycardia
  • hyperthyroidism
  • hypothyroidism
  • convulsions
  • altered consciousness
  • headache
  • dizziness
  • bronchial dilation
  • pneumonia due to drug aspiration
  • pulmonary edema
  • urticaria
  • rash
  • itching
  • erythema
  • toxic epidermal necrolysis
  • fever
  • sweating
  • fluid and electrolyte imbalance

Not everyone experiences these, and they can vary from person to person.

Storage

This drug can deteriorate when exposed to light, so it should be stored in a light-protected, tightly sealed container. The storage temperature should ideally be maintained between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

A slightly yellowish, nearly colorless solution contained in a brown bottle with a faint star anise scent.

Package unit

1CTN: 100ML × 1

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.